Literature DB >> 11743713

Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids.

I Petitpas1, T Grüne, A A Bhattacharya, S Curry.   

Abstract

The primary ligands of human serum albumin (HSA), an abundant plasma protein, are non-esterified fatty acids. In vivo, the majority of fatty acids associated with the protein are unsaturated. We present here the first high-resolution crystal structures of HSA complexed with two important unsaturated fatty acids, the monounsaturated oleic acid (C18:1) and the polyunsaturated arachidonic acid (C20:4). Both compounds are observed to occupy the seven binding sites distributed across the protein that are also bound by medium and long-chain saturated fatty acids. Although C18:1 fatty acid binds each site on HSA in a conformation almost identical with that of the corresponding saturated compound (C18:0), the presence of multiple cis double bonds in C20:4 induces distinct binding configurations at some sites. The observed restriction on binding configurations plausibly accounts for differences in the pattern of binding affinities for the primary sites between polyunsaturated fatty acids and their saturated or monounsaturated counterparts. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743713     DOI: 10.1006/jmbi.2000.5208

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  88 in total

1.  Molecular dynamics simulation studies of betulinic acid with human serum albumin.

Authors:  Chandramouli Malleda; Navjeet Ahalawat; Mahesh Gokara; Rajagopal Subramanyam
Journal:  J Mol Model       Date:  2011-11-11       Impact factor: 1.810

2.  The reactivity of human serum albumin toward trans-4-hydroxy-2-nonenal.

Authors:  Qingyuan Liu; David C Simpson; Scott Gronert
Journal:  J Mass Spectrom       Date:  2012-04       Impact factor: 1.982

3.  Structural determinants of binding of aromates to extracellular matrix: a multi-species multi-mode CoMFA study.

Authors:  Yufen Zhang; Viera Lukacova; Vladimir Bartus; Stefan Balaz
Journal:  Chem Res Toxicol       Date:  2007-01       Impact factor: 3.739

4.  Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats.

Authors:  G Panitsa; A Panitsas; A Potamianou; J Messari; J Vovou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

Review 5.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

6.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

7.  Characterization of the complex between native and reduced bovine serum albumin with aquacobalamin and evidence of dual tetrapyrrole binding.

Authors:  Ilia A Dereven'kov; Luciana Hannibal; Sergei V Makarov; Anna S Makarova; Pavel A Molodtsov; Oskar I Koifman
Journal:  J Biol Inorg Chem       Date:  2018-05-02       Impact factor: 3.358

8.  Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.

Authors:  Moustafa Algamal; Julijana Milojevic; Naeimeh Jafari; William Zhang; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

Review 9.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  The interplay between copper(II), human serum albumin, fatty acids, and carbonylating agent interferes with Cys 34 thiol reactivity and copper binding.

Authors:  Ana Z Penezić; Jelena M Aćimović; Ivan D Pavićević; Vesna B Jovanović; Marija Takić; Ljuba M Mandić
Journal:  J Biol Inorg Chem       Date:  2018-11-19       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.